3-4467058-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_182760.4(SUMF1):c.188G>A(p.Ser63Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.266 in 1,565,330 control chromosomes in the GnomAD database, including 60,974 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_182760.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUMF1 | NM_182760.4 | c.188G>A | p.Ser63Asn | missense_variant | 1/9 | ENST00000272902.10 | NP_877437.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUMF1 | ENST00000272902.10 | c.188G>A | p.Ser63Asn | missense_variant | 1/9 | 1 | NM_182760.4 | ENSP00000272902.5 |
Frequencies
GnomAD3 genomes AF: 0.204 AC: 30956AN: 152060Hom.: 3961 Cov.: 32
GnomAD3 exomes AF: 0.216 AC: 37487AN: 173514Hom.: 4809 AF XY: 0.216 AC XY: 20539AN XY: 95016
GnomAD4 exome AF: 0.273 AC: 385976AN: 1413152Hom.: 57014 Cov.: 39 AF XY: 0.268 AC XY: 187410AN XY: 698174
GnomAD4 genome AF: 0.203 AC: 30953AN: 152178Hom.: 3960 Cov.: 32 AF XY: 0.198 AC XY: 14743AN XY: 74404
ClinVar
Submissions by phenotype
Multiple sulfatase deficiency Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Pars Genome Lab | Jun 15, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 23, 2015 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2018 | Variant summary: SUMF1 c.188G>A (p.Ser63Asn) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.21 in 198742 control chromosomes in the gnomAD database, including 5502 homozygotes. The observed variant frequency is approximately 191 fold above the estimated maximal expected allele frequency for a pathogenic variant in SUMF1 causing Multiple Sulfatase Deficiency phenotype (0.0011), strongly suggesting that the variant is benign. Variant c.188G>A has been reported in individuals affected with Multiple Sulfatase Deficiency and authors listed the variant as a polymorphism (Dierks_2003). To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar and both classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at